Comprehensive review on novel targets and emerging therapeutic modalities for pulmonary arterial Hypertension-Reference-Cited by-同舟云学术

Comprehensive review on novel targets and emerging therapeutic modalities for pulmonary arterial Hypertension

Published:2022-06 Issue: Volume:621 Page:121792
ISSN:0378-5173
Container-title:International Journal of Pharmaceutics
language:en
Short-container-title:International Journal of Pharmaceutics

Author:

Dhoble Sagar,Patravale Vandana,Weaver Edward,Lamprou Dimitrios A.,Patravale Tanmay

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference197 articles.

1. Tyrosine kinase inhibitors are potent acute pulmonary vasodilators in rats;Abe;Am. J. Respir. Cell Mol. Biol.,2011

2. New drug-eluting stents an overview on biodegradable and polymer-free next-generation stent systems;Abizaid;Circulation: Cardiovasc. Interventions,2010

3. Long-circulating (sterically stabilized) liposomes for targeted drug delivery;Allen;Trends Pharmacol. Sci.,1994

4. Liposomal drug delivery systems: From concept to clinical applications;Allen;Adv. Drug Deliv. Rev.,2013

5. Apabetalone for Pulmonary Arterial Hypertension: a Pilot Study - Full Text View - ClinicalTrials.gov [WWW Document], n.d. URL https://clinicaltrials.gov/ct2/show/NCT03655704 (accessed 2.15.21).

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Time Is Running Out in Pulmonary Arterial Hypertension: The Epigenetic Clock Is Clicking;American Journal of Respiratory Cell and Molecular Biology;2024-02

2. Pulmonary arterial hypertension nanotherapeutics: New pharmacological targets and drug delivery strategies;Journal of Controlled Release;2024-01

3. Prostaglandin and prostaglandin receptors: present and future promising therapeutic targets for pulmonary arterial hypertension;Respiratory Research;2023-11-01

4. Bioinformatics analysis of the immune cell infiltration characteristics and correlation with crucial diagnostic markers in pulmonary arterial hypertension;BMC Pulmonary Medicine;2023-08-15

5. Endothelial dysfunction, platelet hyperactivity, hypertension, and the metabolic syndrome: molecular insights and combating strategies;Frontiers in Nutrition;2023-08-08